Method for treating inflammatory disorders

Joan W. Miller, Vassiliki Poulaki, Inflammatory eye disease ,(2005)

James Veal, Kenneth He Huang, Lifeng Geng, Lindsay Hinkley, Jeron Eaves, Gunnar J. Hanson, Thomas Barta, Benzene, pyridine, and pyridazine derivatives ,(2007)

Mariarosaria Bucci, Fiorentina Roviezzo, Carla Cicala, William C Sessa, Giuseppe Cirino, Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. British Journal of Pharmacology. ,vol. 131, pp. 13- 16 ,(2000) , 10.1038/SJ.BJP.0703549

Stephen Wax, Monica Piecyk, Beatrice Maritim, Paul Anderson, None, Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts. Arthritis & Rheumatism. ,vol. 48, pp. 541- 550 ,(2003) , 10.1002/ART.10780

Junghyun Chae, Zachary Demko, Weiwen Ying, Zhenjian Du, Kevin Foley, David James, Teresa Przewloka, Minghu Song, Shijie Zhang, Howard P Ng, Hao Li, Dinesh U Chimmanamada, Lijun Sun, Keizo Koya, Dan Zhou, Shuzhen Qin, Chi-Wan Lee, Triazole compounds that modulate HSP90 activity ,(2007)

David C. Myles, Yaoquan Liu, Zong-Qiang Tian, Zhan Wang, 11-O-methylgeldanamycin compounds ,(2004)

Weiwen Ying, Dinesh U. Chimmanamada, David James, Junghyun Chae, Shijie Zhang, Teresa Przewloka, Chi-Wan Lee, Synthesis of triazole compounds that modulate HSP90 activity ,(2007)

David Strehlow, Use of geldanamycin and related compounds for prophylaxis or treatment of fibrogenic disorders ,(2001)

Weiwen Ying, Zhenjian Du, Shijie Zhang, Kevin Foley, Pyrazole compounds that modulate HSP90 activity ,(2006)